NDRG1 and prostate carcinoma: In contrast to previous investigations in colorectal and prostate cancer cells 19, Vimentin was inhibited after NDRG1 silencing in MDA-MB-231 and MDA-MB-436 cells treated with TGFβ1, which was not seen in SUM159 and BT549 (Fig. 3E).